Serial Number:
86423411
Mark:
REXULTI BREXPIPRAZOLE
Status:
Abandoned-No Statement of Use filed
Status Date:
12-07-2015
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; vaccines; preparations, substances, reagents and agents for medical diagnostic and medical purposes; all of the foregoing containing brexpiprazole in whole or substantial part
Mark Description:
The mark consists of the wording "REXULTI" in a stylized font, and the wording "BREXPIPRAZOLE" below "REXULTI", with two interlocked triangles at the left of the mark.
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
03-10-2015
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
12-07-2015
Business Name:
HOLLAND & HART LLP
Correspondent Name: